This session will discuss how large electronic health records (EHR) databases have been increasingly used by the pharmaceutical industry to support drug development and life cycle management in a variety of fields/activities such as pharmacoepidemiology, pharmacovigilance, postauthorization safety study, comparative effectiveness research, utilization pattern analysis, protocol refinement, clinical trial recruitment and cost-effectiveness assessment.